VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP.
about
Pharmacologic interventions for the prevention and treatment of retinopathy of prematurityExogenous leukemia inhibitory factor (LIF) attenuates retinal vascularization reducing cell proliferation not apoptosisExpression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurityN-CAM exhibits a regulatory function in pathological angiogenesis in oxygen induced retinopathyOrientation of endothelial cell division is regulated by VEGF signaling during blood vessel formationStudies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis)Anti-vascular endothelial growth factor therapies in ophthalmology: current use, controversies and the future.Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic optionsBone morphogenetic protein-4 enhances vascular endothelial growth factor secretion by human retinal pigment epithelial cellsExpression of protein kinase CK2 in astroglial cells of normal and neovascularized retinaEffect of VEGF trap on normal retinal vascular development and oxygen-induced retinopathy in the dog.A higher incidence of intermittent hypoxemic episodes is associated with severe retinopathy of prematurity.Vascular endothelial growth factor biology: clinical implications for ocular treatmentsInner retinal oxygen metabolism in the 50/10 oxygen-induced retinopathy model.Defective angiogenesis, endothelial migration, proliferation, and MAPK signaling in Rap1b-deficient mice.Intravitreal injection of TIMP3 or the EGFR inhibitor erlotinib offers protection from oxygen-induced retinopathy in mice.Vascular endothelial growth factor (VEGF)-A: role on cardiac angiogenesis following myocardial infarction.Serum VEGF and CFH in exudative age-related macular degenerationVascular endothelial growth factor in eye disease.Ranibizumab in neovascular age-related macular degeneration.Differential expression of vascular endothelial growth factor isoforms and receptor subtypes in the infarcted heart.A murine model for retinopathy of prematurity identifies endothelial cell proliferation as a potential mechanism for plus disease.Short hairpin RNA-mediated knockdown of VEGFA in Müller cells reduces intravitreal neovascularization in a rat model of retinopathy of prematurity.Incidence of severe retinopathy of prematurity before and after a modest reduction in target oxygen saturation levelsQuantitative analyses of retinal vascular area and density after different methods to reduce VEGF in a rat model of retinopathy of prematurity.The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: knowledge from the 50/10 OIR model.Targeting Müller cell-derived VEGF164 to reduce intravitreal neovascularization in the rat model of retinopathy of prematurity.Protective effect of maternal uteroplacental insufficiency on oxygen-induced retinopathy in offspring: removing bias of premature birthPathophysiology and mechanisms of severe retinopathy of prematurity.Growth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes MellitusExpression of p-STAT3 and vascular endothelial growth factor in MNNG-induced precancerous lesions and gastric tumors in ratsAdvances in understanding and management of retinopathy of prematurity.Antivascular endothelial growth factor agents for neovascular age-related macular degeneration.The neurovascular relation in oxygen-induced retinopathy.Expression levels of vascular endothelial growth factors a and C in patients with peptic ulcers and gastric cancer.Intraocular and systemic levels of vascular endothelial growth factor in advanced cases of retinopathy of prematurity.Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity.Hypoxia-induced expression of VEGF splice variants and protein in four retinal cell types.VEGF-mediated STAT3 activation inhibits retinal vascularization by down-regulating local erythropoietin expression.Increased angiogenic factors associated with peripheral avascular retina and intravitreous neovascularization: a model of retinopathy of prematurity.
P2860
Q26772889-3523C875-1E1B-42A3-940E-6942E6F85073Q28566217-2D41BE33-FA2E-4207-9C19-D2ACC399CCDCQ28583644-95256CD0-EF14-4120-AC77-D6EE31158F56Q28743741-D7A7229E-8257-4F51-8891-6BE8C0E91A6AQ30478950-2465C7D1-293F-40C1-83EE-E94B55230EF1Q33787955-6D9E5DBB-8E85-4E7C-BC8A-719F92407EAAQ34554380-C2537611-5644-4612-B7FC-8D25EFB462CBQ34704214-CE373F23-9EDF-4B75-B8A2-C10EA9515AA2Q35012843-877C8BA1-D356-44AE-8979-463949BE6B6AQ35088245-F6776583-FD1C-45B4-A74F-7508E5791319Q35221047-F4360A4B-A0BF-4D87-ADF6-9788CE615770Q35597168-CCD973E7-EEF3-4AFB-8791-6E08D82BD160Q35762769-17104B65-FC72-4C77-B829-A85BC86CD490Q36291702-1B3CCA5A-6A9F-4464-87EC-6F1E64D1E1BDQ36478425-1852AF3C-A391-4AB4-8FCA-FAEFABB5723AQ36581303-EF027C44-403B-44E7-90D3-597AFC729F77Q36773118-AFD2C45F-6787-4F66-A555-071F547904B2Q36860915-44D8E04D-A50F-4F40-A621-1415C2D4CA17Q36929380-D67EA060-8117-4279-9787-21F10AE5D099Q37018974-6844B209-60F2-4737-A0DB-5DBFE2A84B18Q37022081-BB35BC8D-38F1-4AB8-816F-6E02B0FFB85CQ37082206-2696B831-D31A-4F6F-894E-EFC5E61D62A0Q37149035-9C9C882A-3BB5-4DF9-BA69-AACBCD664901Q37250919-85410C7F-445C-40FF-B46F-C544EC426C76Q37561227-8F4D2BA7-AB30-43D7-BD16-5DD3393BF8CDQ37565247-1815185D-8AE4-46F8-B903-983B93047B31Q37577214-1DA24223-7D1B-4F1E-8632-99DA8304A082Q37640165-91D85806-FA2E-4B3E-96BD-0F520FC11B1EQ38274655-746197C5-2D8E-48BD-A947-1601AAEBE410Q38928508-F0C00FEE-FC9F-424C-8FEA-FC76E3406814Q38965315-E3A8AA06-DEC3-4C21-BF21-FE3E9B879A85Q39052915-0BCCBFFA-322C-4E9E-BC7B-3324B7D11A54Q39519501-CCCB8943-D264-43E7-99E3-5CFD6699CC92Q39867594-9E08F642-C492-414A-B8B8-C5F7BF4484A0Q41695649-305063E9-211E-40C0-A179-C83599E06733Q41762627-E833B44F-C44F-4208-BA02-940EF8B0CE8AQ41829449-16737F19-31AC-4691-BEC9-996BA1BBA0EFQ41877512-7019B81F-9520-43B4-8749-45F06ACB5901Q42044757-39754D60-32CF-4775-B2CA-B4ABE5F060C2Q42155672-5509F0AE-1FAE-485D-9EAC-13C10F157868
P2860
VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
VEGF isoforms and their expres ...... ia: relevance to clinical ROP.
@ast
VEGF isoforms and their expres ...... ia: relevance to clinical ROP.
@en
type
label
VEGF isoforms and their expres ...... ia: relevance to clinical ROP.
@ast
VEGF isoforms and their expres ...... ia: relevance to clinical ROP.
@en
prefLabel
VEGF isoforms and their expres ...... ia: relevance to clinical ROP.
@ast
VEGF isoforms and their expres ...... ia: relevance to clinical ROP.
@en
P2093
P2860
P1433
P1476
VEGF isoforms and their expres ...... xia: relevance to clinical ROP
@en
P2093
Janet R McColm
M Elizabeth Hartnett
Pete Geisen
P2860
P304
P577
2004-07-21T00:00:00Z